This site provides information on the conduct of human subjects research and FDA-regulated clinical trials during the COVID-19 pandemic. Operational changes to the UW-Madison and UW Health clinical research infrastructure programs (e.g., Office of Clinical Trials, Pharmaceutical Research Center, Clinical Research Unit) will be regularly updated. Additionally, this site will share best practices and resources across the many UW-Madison schools, colleges, and departments that conduct human subjects research.
COVID-19 Quicklinks
Check the below sites for other campus updates.
CRU Releases *Updated* Study Team & Participant Guidance
The Clinical Research Unit (CRU) has released updated guidance to keep study teams and participants informed.
August 17, 2020Updated Template Letter for Sharing with Clinical Research Sponsors
Betsy Nugent, CCRO, has provided a follow-up letter to further inform stakeholders about current clinical research operations. Please share the updated letter with research sponsors and include within regulatory binders as necessary. COVID19 Letter …
August 4, 2020Free FDA-sponsored Course | July 27-30
Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens
June 24, 2020Updated Template Letter for Sharing with Clinical Research Sponsors
In March, Betsy Nugent, CCRO, provided a letter to communicate modifications of clinical research operations as a result of COVID-19. Ms. Nugent has provided a follow-up letter to further inform stakeholders about current operations. …
April 29, 2020External Research Monitor Remote Access to Health Link
Effective April 13, 2020, research monitors may obtain remote, view-only access to Health Link. External Research Monitor REMOTE access to Health Link (Email 4-10-20) EpicCare Link for Research Monitors RC guide (4-10-20) Research Monitor Care …
April 10, 2020‘They All Have This Superpower’: Researchers Want Plasma From Recovered COVID-19 Patients
Wisconsin Public Radio
April 6, 2020- Read more